Science Daily: Pharmacology News

AUGUST 9, 2024

Scientists have recovered the first long section of rocks that originated in the Earth's mantle, the layer below the crust and the planet's largest component. The rocks will help unravel the mantle's role in the origins of life on Earth, the volcanic activity generated when it melts, and how it drives the global cycles of important elements such as carbon and hydrogen.

143

143

BioPharma Drive: Drug Pricing

AUGUST 9, 2024

The decision to turn down an application from Lykos Therapeutics comes at a pivotal time for psychedelics research, which, after decades of dismissal, has recently gained momentum.

Therapies 128

Therapies FDA Research 128

Science Daily: Pharmacology News

AUGUST 9, 2024

A 'loopy' discovery in bacteria is raising fundamental questions about the makeup of our own genome -- and revealing a potential wellspring of material for new genetic therapies.

Therapies 141

Therapies 141

BioPharma Drive: Drug Pricing

AUGUST 9, 2024

Recent data from J.P. Morgan indicates early-stage startups are getting smaller upfront payments in alliances than a few years ago, a trend industry insiders attribute to weaker leverage in deal talks.

Drugs 130

Drugs 130

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Science Daily: Pharmacology News

AUGUST 9, 2024

Scientists report that gamma frequency light and sound stimulation preserves myelination in mouse models and reveal molecular mechanisms that may underlie the benefit.

127

127

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- In findings that offer compelling evidence of the power of childhood vaccines, a new government report shows the routine shots have prevented hundreds of millions of illnesses, tens of millions of hospitalizations and more.

Vaccine 111

Vaccine Government Hospitals 111

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- Pollen is a known trigger for seasonal allergies and asthma, but new research suggests that certain plant species release pollen that are especially tough on asthmatics.Species-specific pollen alerts could help keep people.

Research 115

Research 115

Science Daily: Pharmacology News

AUGUST 9, 2024

A discovery may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused by defective stem cells, which produce all the body's different blood cells.

Disease 123

Disease 123

BioPharma Drive: Drug Pricing

AUGUST 9, 2024

The deal hands Merck a cancer medicine already in human testing, but that the company sees as a potential treatment for autoimmune conditions, too.

Disease 117

Disease Treatment 117

Science Daily: Pharmacology News

AUGUST 9, 2024

While seeking to unravel how marine algae create their chemically complex toxins, scientists have discovered the largest protein yet identified in biology. Uncovering the biological machinery the algae evolved to make its intricate toxin also revealed previously unknown strategies for assembling chemicals, which could unlock the development of new medicines and materials.

120

120

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- A wearable brain scanner could improve research into Parkinson’s disease, dementia and other debilitating disorders, new research shows.The brain scanner -- called the Ambulatory Motion-enabling PET (AMPET) -- fits on a p.

Disease 98

Disease Research 98

Science Daily: Pharmacology News

AUGUST 9, 2024

Researchers invented a technique that uses a specialized light projector and a photosensitive chemical additive to imprint two- and three-dimensional images inside any polymer. The light-based engraving remains in the polymer until heat or light are applied, which erases the image and makes it ready to use again. The technology is intended for any situation where having detailed, precise visual data in a compact and easily customizable format could be critical, such as planning surgeries and dev

Research 115

Research 115

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- People who are nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray.The U.S. Food and Drug Administration on Friday announced that it has approved neffy, the first.

FDA Approval 98

FDA Approval FDA Drugs 98

Science Daily: Pharmacology News

AUGUST 9, 2024

In September 2023, a megatsunami in remote eastern Greenland sent seismic waves around the world, piquing the interest of the global research community. The event created a week-long oscillating wave in Dickson Fjord, according to a new report in The Seismic Record.

Research 93

Research 93

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- There’s a good chance that if one child in a family has autism, another will also develop the disorder, a new study suggests.Children are seven times more likely to be diagnosed with autism if an older sibling has the d.

98

98

Conversations in Drug Development Trends

AUGUST 9, 2024

Authors: Matt Cooper, PhD, Executive Director, Therapeutic Strategy Lead, Oncology; Megan Morrison, Vice President, Asia Pacific Strategy Lead Adaptive trial designs have become essential in oncology, offering a flexible and efficient approach for conducting clinical trials. By allowing protocol adjustments based on interim data analysis, these designs preserve the integrity of studies while effectively addressing the unique challenges of multi-regional clinical trials (MRCTs).

Trials 80

Trials Clinical Trials Regulations FDA 80

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- Patients discharged from a hospital stay are bringing antibiotic-resistant “superbugs” home with them, a new study warns.Family members of recently discharged patients are 71 times more likely to get a MRSA infection after th.

Hospitals 98

Hospitals 98

Drug Target Review

AUGUST 9, 2024

What is drug formulation? Drug formulation is the process of designing and producing a final medicinal product from an active pharmaceutical ingredient (API). This involves combining the API with various excipients – non-active ingredients that enhance the drug’s stability, solubility, bioavailability and generally enhance the API’s ability to interact with the pharmacological target. 1 The goal is to create a dosage form that delivers the drug effectively to the intended site of action with opt

Science 59

Science Drugs Compliance Drug Development 59

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- Folks can overcome their genetic risk for type 2 diabetes through healthy diet and regular exercise, a new study says.A healthy lifestyle reduced the risk of type 2 diabetes by 70% among a group of people with a high genetic.

98

98

Perficient: Drug Development

AUGUST 9, 2024

Welcome to another insightful installment in our UX in Universal Design series! This time, we’ll be focusing on the importance of large touch targets within health systems. As healthcare increasingly relies on digital interfaces—whether through patient portals, check-in kiosks, or mobile health apps—it’s crucial to ensure that these technologies are accessible to all users, including those with physical disabilities or dexterity challenges.

Hospitals 59

Hospitals Disease 59

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- Women exposed to TikTok videos that make eating disorders look cool and glamorous tend to have worse body image, a new study finds.These videos include what researchers call "pro-anorexia" clips, as well as other videos.

Research 96

Research 96

Agency IQ

AUGUST 9, 2024

By Laura DiAngelo, MPH Last month, the FDA published a new draft guidance document on diversity action plans. While the new version of the guidance is greatly expanded as compared to an earlier version from 2022, it has left plenty of important questions unanswered. In this piece, AgencyIQ answers some of the most common questions we’ve received about the guidance – and raise a few of our own.

FDA 59

FDA 59

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- People who are nervous about administering a rescue shot for anaphylaxis finally have a new alternative in a nasal spray. The U.S. Food and Drug Administration on Friday announced that it has approved neffy, the first.

FDA Approval 52

FDA Approval FDA Drugs 52

Agency IQ

AUGUST 9, 2024

By Amanda Conti In its inaugural meeting, FDA’s Genetic Metabolic Diseases Advisory Committee heard Zevra’s second try for arimoclomol to treat ultra-rare lysosomal storage disorder Niemann-Pick Type C. The committee voted 11-5 in favor of the drug’s effectiveness, leaving FDA to test the limits of its regulatory flexibility toward post hoc analysis and lackluster confirmatory evidence.

Disease 59

Disease FDA Drugs 59

Drug Patent Watch

AUGUST 9, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 52

Drugs Marketing 52

Agency IQ

AUGUST 9, 2024

By Sebastian Godoy, MPH Earlier this year, the EMA hosted a multi-stakeholder workshop to discuss regulatory issues surrounding drug development of psychedelic products. Despite intense interest in their use, no psychedelic products are approved in the European Regulatory Medicines Network, with drug developers facing legal and regulatory obstacles, including a dearth of guidance.

Drug Development 59

Drug Development Production Drugs 59

Drugs.com

AUGUST 9, 2024

FRIDAY, Aug. 9, 2024 -- Radiation therapy following surgery can keep breast cancer from returning for up to 10 years, a new study claims.The study supports the current standard of care for early-stage breast cancer, which involves surgery followed.

Therapies 52

Therapies 52

Agency IQ

AUGUST 9, 2024

By Scott Stephens, MPA The European Commission plans to implement exemptions introduced under the Stockholm Convention’s 2023 ban of UV-328, an ultraviolet-light absorbing persistent organic pollutant (POP). Specifically, the EU executive’s proposal seeks to harmonize the POPs Regulation, carving out exclusions for mechanical separators in blood collection tubes, triacetyl cellulose film in polarizers, and photographic paper, among other exempted articles containing UV-328.

Regulations 59

Regulations 59

Antidote

AUGUST 9, 2024

Obesity is a common condition, impacting nearly 3 in 4 adults over the age of 20 in the United States. Research into obesity medications has increased significantly in recent years, resulting in novel weight-management drugs that are continuing to drive interest and demand. However, although obesity disproportionately impacts people of color, many of these studies are still made up of predominantly white individuals, creating a gap in knowledge about the effectiveness of these medications.

Research 52

Research Drugs 52

Drug Channels

AUGUST 9, 2024

Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Chris reviews recent developments for the Inflation Reduction Act of 2022 (IRA). He then recommends four IRA-related adjustments that manufacturers should make to their patient support programs. To learn more, register for ConnectiveRx’s free webinar on September 17: IRA Reality Check: Adapting Hub and Copay Programs to Ensure Patient Access and Affordability.

Marketing 52

Marketing Drugs 52

Agency IQ

AUGUST 9, 2024

Commission proposes exemptions to UV-328 ban under POPs Regulation The European Commission plans to implement exemptions introduced under the Stockholm Convention’s 2023 ban of UV-328, an ultraviolet-light absorbing persistent organic pollutant (POP). Specifically, the EU executive’s proposal seeks to harmonize the POPs Regulation, carving out exclusions for mechanical separators in blood collection tubes, triacetyl cellulose film in polarizers, and photographic paper, among other exempted artic

Regulations 40

Regulations Production International Marketing 40

Drug Patent Watch

AUGUST 9, 2024

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Austria.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals 52

DrugBank

AUGUST 9, 2024

Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail.  The average cost of bringing a new drug to market is about $2.6 billion, with a development timeline spanning 10 to 15 years. Moreover, the probability of success for a drug candidate entering clinical trials is only around 10%, highlighting the substantial risks involved.

Pharmaceuticals 76

Pharmaceuticals Research Pharmaceutical Companies Clinical Trials 76

Agency IQ

AUGUST 9, 2024

FDA’s Diversity Action Plan: Questions, answers, and what we (don’t) know so far Last month, the FDA published a new draft guidance document on diversity action plans. While the new version of the guidance is greatly expanded as compared to an earlier version from 2022, it has left plenty of important questions unanswered. In this piece, AgencyIQ answers some of the most common questions we’ve received about the guidance – and raise a few of our own.

Science 40

Science FDA Production Trials 40